Voloridge Investment Management, LLC Pliant Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$14.58 - $20.15 $939,826 - $1.3 Million	-64,460 Reduced 50.6%	62,941 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $731,903 - $1.23 Million	-40,392 Reduced 24.07%	127,401 $2.31 Million
Q1 2023 May 15, 2023	SELL	$18.73 - $36.26 $97,339 - $188,443	-5,197 Reduced 3.0%	167,793 $4.46 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $1.17 Million - $1.75 Million	68,683 Added 65.85%	172,990 $3.34 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $800,034 - $2.53 Million	104,307 New	104,307 $2.18 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.